Physician Payments Sunshine Act (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Physician Payments Sunshine Act" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

2^nd place

3^rd place

730^th place

2,194^th place

low place

low place

3,257^th place

1,028^th place

57^th place

4^th place

18^th place

118^th place

ama-assn.org

« Physician Financial Transparency Reports (Sunshine Act) », American Medical Association, American Medical Association,‎ 2013 (lire en ligne, consulté le 3 juin 2013).

« S.301 - Physician Payments Sunshine Act of 2009 - 111th Congress (2009-2010) », Library of Congress (Congress.gov), 2009 (consulté le 13 avril 2017)

Campbell, « Doctors and Drug Companies — Scrutinizing Influential Relationships », New England Journal of Medicine, vol. 357, n^o 18,‎ 2007, p. 1796–1797 (PMID 17978288, DOI 10.1056/NEJMp078141)
Carpenter, « A Unique Researcher Identifier for the Physician Payments Sunshine Act », JAMA: The Journal of the American Medical Association, vol. 305, n^o 19,‎ 2011, p. 2007–2008 (PMID 21586717, PMCID 3143068, DOI 10.1001/jama.2011.651).
« Effect of financial disclosure laws on physician prescribing », Archives of Internal Medicine, vol. 172, n^o 10,‎ 2012, p. 819–821 (PMID 22636826, PMCID 4007047, DOI 10.1001/archinternmed.2012.1210).
Perlis et Perlis, « Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs », PLoS ONE, vol. 11, n^o 5,‎ 16 mai 2016, e0155474 (ISSN 1932-6203, PMID 27183221, PMCID 4868346, DOI 10.1371/journal.pone.0155474, Bibcode 2016PLoSO..1155474P).
Jane Robertson, Ray Moynihan, Emily Walkom et Lisa Bero, « Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals », PLOS Medicine, vol. 6, n^o 11,‎ 3 novembre 2009, e1000128 (PMID 19885393, PMCID 2764857, DOI 10.1371/journal.pmed.1000128)

Perlis et Perlis, « Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs », PLoS ONE, vol. 11, n^o 5,‎ 16 mai 2016, e0155474 (ISSN 1932-6203, PMID 27183221, PMCID 4868346, DOI 10.1371/journal.pone.0155474, Bibcode 2016PLoSO..1155474P).

Perlis et Perlis, « Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs », PLoS ONE, vol. 11, n^o 5,‎ 16 mai 2016, e0155474 (ISSN 1932-6203, PMID 27183221, PMCID 4868346, DOI 10.1371/journal.pone.0155474, Bibcode 2016PLoSO..1155474P).

Lazarus, « The Physician Payment Sunshine Act is here: Are you ready? », kevinmd.com, 12 avril 2013 (consulté le 3 juin 2013)

Campbell, « Doctors and Drug Companies — Scrutinizing Influential Relationships », New England Journal of Medicine, vol. 357, n^o 18,‎ 2007, p. 1796–1797 (PMID 17978288, DOI 10.1056/NEJMp078141)
Carpenter, « A Unique Researcher Identifier for the Physician Payments Sunshine Act », JAMA: The Journal of the American Medical Association, vol. 305, n^o 19,‎ 2011, p. 2007–2008 (PMID 21586717, PMCID 3143068, DOI 10.1001/jama.2011.651).
« Effect of financial disclosure laws on physician prescribing », Archives of Internal Medicine, vol. 172, n^o 10,‎ 2012, p. 819–821 (PMID 22636826, PMCID 4007047, DOI 10.1001/archinternmed.2012.1210).
Perlis et Perlis, « Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs », PLoS ONE, vol. 11, n^o 5,‎ 16 mai 2016, e0155474 (ISSN 1932-6203, PMID 27183221, PMCID 4868346, DOI 10.1371/journal.pone.0155474, Bibcode 2016PLoSO..1155474P).
Jane Robertson, Ray Moynihan, Emily Walkom et Lisa Bero, « Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals », PLOS Medicine, vol. 6, n^o 11,‎ 3 novembre 2009, e1000128 (PMID 19885393, PMCID 2764857, DOI 10.1371/journal.pmed.1000128)